WHO updates rules calling for methadone or buprenorphine for OUD
Alcoholism & Drug Abuse Weekly · 13.04.2026 · 38 (15) · 8-8
DOI: 10.1002/adaw.34876 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcoholism & Drug Abuse Weekly, online erschienen am 10.04.2026. Verfasst von Alison Knopf.
Abstract (Originalsprache)
The World Health Organization (WHO) has called on treatment providers worldwide to rely on two treatments for opioid use disorder (OUD): methadone and buprenorphine. Worldwide, OUD is a major contributor to morbidity and mortality. According to WHO, of 600,000 deaths attributed to drug use, about 450,000 are due to opioid use.
Zitieren
APA
Knopf, A. (2026). WHO updates rules calling for methadone or buprenorphine for OUD. Alcoholism & Drug Abuse Weekly, 38(15), 8-8. https://doi.org/10.1002/adaw.34876
Vancouver
Knopf A. WHO updates rules calling for methadone or buprenorphine for OUD. Alcoholism & Drug Abuse Weekly. 2026;38(15):8-8. doi:10.1002/adaw.34876
BibTeX
@article{Knopf2026,
author = {Knopf, Alison},
title = {WHO updates rules calling for methadone or buprenorphine for OUD},
journal = {Alcoholism & Drug Abuse Weekly},
year = {2026},
volume = {38},
number = {15},
pages = {8--8},
doi = {10.1002/adaw.34876}
}
EUVIMED